Xarelto is a member of a new class of oral anticoagulant medications proscribed to patients who suffer from a serious medical condition known as atrial fibrillation (Afib). Afib patients are at increased risk for certain types of serious medical conditions related to clotting disorders. When an Afib patient in not…
Articles Posted in Xarelto
Studies on Using Pradaxa and Xarelto During Surgery
Pradaxa, Xarelto, and Eliquis are all members of a relatively new class of drugs known as new oral anticoagulants (NOACs). These drugs were designed for patients who suffer from a medical condition known as atrial fibrillation (Afib). Afib patients need a blood thinning medication to prevent deep vein clots from…
Bayer Hopes for New Market for Xarelto
The general public is becoming more aware of the dangers of Xarelto. The problem with Xarelto is it has been shown to cause serious internal bleeding disorders, clotting disorders and other serious heath problems. There is currently an antidote for the irreversible symptoms of Xarelto bleeding disorders, but it is…
Xarelto Lawsuit Removed to Federal Court
Xarelto is an anticoagulant medication manufactured by Bayer AG, the German pharmaceutical giant, and Janssen, a subsidiary of Johnson & Johnson, markets it in the United States. Xarelto is one of three relatively new forms of medication marketed to treat patients who suffer from a condition known as atrial fibrillation…
Report: Xarelto Sales Down
While Bayer AG, the German pharmaceutical giant, has seen a recent increase in quarter-over-quarter profits, sales numbers for their bestselling drug, Xarelto, have actually dropped this past quarter for the first time since the United States Food and Drug Administration (FDA) approved it for market. Xarelto is a member of…
A Look at Xarelto Lawsuits
Xarelto, like Eliquis and Pradaxa, are members of a class of drugs known as New Oral Anticoagulants (NOACs). While, technically, they are not a blood thinner like Coumadin (Warfarin), as they are closer to a class of medications known as statins, their respective makers hope they will go head-to-head with…
Plaintiff Demands $4.5 Million in Xarelto Injury Lawsuit
According to a recent news feature from the Madison Record, a woman in Texas is suing Bayer Pharmaceuticals AG, and its United States marketing partner Janssen Pharmaceuticals (Johnson & Johnson) for injuries she alleges was a result of her Xarelto prescription. Xarelto is the brand name for a drug known…
A Look at the Blood Thinner Marketing Blitz
These days it is nearly impossible to watch television without seeing commercials for one of three drugs, which are part of a new group of blood thinning medications known as New Oral Anticoagulants (NOACs). This relatively new class of drugs includes big names like Xarelto, Eliquis, and Pradaxa. Xarelto makers,…
Pradaxa Makers Banking on New Antidote to Win Sales War with Warfarin
Patients who have a serious health condition known as atrial fibrillation (Afib) are required to take blood-thinning medications to prevent stroke, heart disease, pulmonary embolism (PE) and other serious clotting disorders. Traditionally, this means taking Warfarin. Warfarin is a long existing blood thinning medication now available in generic form. While…
Xarelto Makers Set Sights on Warfarin Despite Bleeding Risk
Xarelto, like Eliquis and Pradaxa, is a blood thinner known as a New Oral Anticoagulant (NOAC) or Factor Xa Inhibitor. Patients at risk for heart disease or with clotting disorders are often required to take an anticoagulant to prevent stroke and other serious medical conditions. The traditional therapy used by…